Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Boehringer Ingelheim
Ownership Structure: privately held
Headquartered in: Germany
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $885,844,089
Number of records: 14
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
| safety-related offenses | $650,015,000 | 2 |
| healthcare-related offenses | $108,500,000 | 3 |
| competition-related offenses | $100,000,000 | 2 |
| government-contracting-related offenses | $26,900,000 | 5 |
| employment-related offenses | $429,089 | 2 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
| drug or medical equipment safety violation | $650,000,000 | 1 |
| off-label or unapproved promotion of medical products | $108,500,000 | 3 |
| price-fixing or anti-competitive practices | $100,000,000 | 2 |
| False Claims Act and related | $26,900,000 | 5 |
| employment discrimination | $379,089 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year  | Agency | Penalty Amount |
| Boehringer Ingelheim Pharmaceutical, Inc. | labor relations violation | 2004 | NLRB | $50,000 |
| Boehringer Ingelheim Corp. | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
| Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
| Boehringer Ingleheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
| Boehringer Ingelheim Pharmaceuticals Inc. | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
| Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
| Boehringer-Ingelheim Pharmaceuticals, Inc. | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS | aviation safety violation | 2014 | FAA | $15,000 |
| Boehringer Ingelheim International | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
| Boehringer Ingelheim Pharma GmbH | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
| Boehringer Ingelheim Pharma GmbH | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
| Boehringer Ingelheim Animal Health USA Inc. | employment discrimination | 2020 | OFCCP | $379,089 |
